Orphazyme is Biotechnology in Denmark that focus on Type C business. Founded in 2009. They cover business area such as Heat Shock Proteins, commercialization, novel therapeutic, neurodegenerative rare disease, Arimoclomol, development, four severe orphan disease, NPC, Gaucher disease, Amyotrophic Lateral Sclerosis, (ALS, Inclusion Body Myositis, IBM.
2009
( 15 years old in 2024 )
Type C
-
Ole Maaløes Vej 3
2200 Copenhagen
Denmark
Private
Heat Shock Proteinscommercializationnovel therapeuticneurodegenerative rare diseaseArimoclomoldevelopmentfour severe orphan diseaseNPCGaucher diseaseAmyotrophic Lateral Sclerosis(ALSInclusion Body MyositisIBM
* We use standard office opening hours in near Orphazyme's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Orphazyme is Biotechnology business from Denmark that founded in 2009 (15 years old in 2024), Orphazyme business is focusing on Type C.
Orphazyme headquarter office and corporate office address is located in Ole Maaløes Vej 3 2200 Copenhagen Denmark.
Orphazyme was founded in Denmark.
In 2024, Orphazyme is currently focus on Type C sector.
Above is snippet of Google Trends for "Type C" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Orphazyme, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
